Corient Private Wealth LLC

Position in DTIL — Precision Biosciences Inc

CIK 1948780 MIAMI, FL

Position in DTIL

as of Jun 30, 2026 · filed Aug 17, 2026 Compact

Position Value

$1,926,155

+$1,870,419 QoQ

Shares Held

245,058

+70.4% QoQ

Ownership

0.888%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#16

of 94 holders

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Corient Private Wealth LLC holds $250,401,460 across 107 Biotechnology names. DTIL ranks #30 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	112,098	$55,682,439
2	IONS	Ionis Pharmaceuticals Inc	196,791	$15,603,558
3	HALO	Halozyme Therapeutics, Inc.	187,447	$14,671,476
4	KRYS	Krystal Biotech, Inc.	32,580	$12,109,008
5	TECH	BIO-TECHNE Corp	122,377	$8,645,935
6	REGN	Regeneron Pharmaceuticals, Inc.	13,758	$8,578,663
7	ALNY	Alnylam Pharmaceuticals, Inc.	23,797	$7,163,610
8	CLDX	Celldex Therapeutics, Inc.	186,110	$6,925,153

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,926,155	245,058	+70.4%	Shares	Sole	2026-08-17
2026-03-31	$55,736	143,852	+1338.5%	Shares	Sole	2026-05-15
2025-12-31	$41,600	10,000	0.0%	Shares	Sole	2026-03-09
2025-09-30	$55,200	10,000	-90.1%	Shares	Sole	2025-11-14
2025-06-30	$425,065	101,206	+400.9%	Shares	Sole	2025-09-26
2024-12-31	$76,973	20,203	+46.7%	Shares	Sole	2025-02-10
2024-09-30	$123,397	13,772	0.0%	Shares	Sole	2024-11-12
2024-06-30	$134,001	13,772	+15.9%	Shares	Sole	2024-08-13
2024-03-31	$161,106	11,881	-94.8%	Shares	Sole	2024-05-09
2023-12-31	$83,045	227,521	+229.0%	Shares	Sole	2024-02-09
2023-09-30	$23,582	69,156	+0.6%	Shares	Sole	2023-11-03
2023-06-30	$36,156	68,738	-0.6%	Shares	Sole	2023-08-10
2023-03-31	$52,143	69,156	+407.8%	Shares	Sole	2023-05-15
2022-12-31	$16,207	13,620	—	Shares	Sole	2023-02-15
No filing history on record for this holder in this stock.